Roxicet and Compazine drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Roxicet (acetaminophen; oxycodone hydrochloride) and Compazine (prochlorperazine maleate). Common drug interactions include gastrointestinal haemorrhage among females and actinomycotic skin infection among males.
The phase IV clinical study analyzes what interactions people have when they take Roxicet and Compazine. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.
What is Roxicet?
Roxicet has active ingredients of acetaminophen; oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 2,254 Roxicet users. Check the latest studies of Roxicet.
What is Compazine?
Compazine has active ingredients of prochlorperazine maleate. It is often used in indigestion. eHealthMe is studying from 13,646 Compazine users. Check the latest studies of Compazine.
11 people who take Roxicet and Compazine together, and have interactions are studied.

What are the common drug interactions of Roxicet and Compazine, by gender? *:
female:
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Alopecia (absence of hair from areas of the body)
- Alopecia areata (patchy baldness that typically begins with rapid hair loss)
- Alopecia totalis (loss of all head hair)
- Anaemia (lack of blood)
- Catheter site erythema (redness of skin at catheter site)
- Catheter site swelling
- Chest pain
- Chronic left ventricular failure (long lasting functional impairment of left ventricle of heart)
- Decreased appetite
male:
- Actinomycotic skin infection (infectious and inflammatory diseases affect the skin and the oral mucosa)
- Acute sinusitis
- Bone disorder
- Bone pain
- Breast calcifications (deposits of calcium that can be seen on a mammogram of the breast)
- Breast cancer metastatic
- Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
- Cellulitis (infection under the skin)
- Cervix inflammation
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
What are the common drug interactions of Roxicet and Compazine, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Anxiety
- Emotional distress
- General physical health deterioration (weak health status)
- Injury
- Pulmonary embolism (blockage of the main artery of the lung)
40-49:
- Death
- Fatigue (feeling of tiredness)
- Malignant pleural effusion (a condition in which cancer causes an abnormal amount of fluid to collect between the thin layers of tissue lining of lung)
- Metastases to kidney (cancer spreads to kidney)
- Muscular weakness (muscle weakness)
- Proteinuria (presence of protein in the urine)
- Wheezing (a high-pitched whistling sound made while you breath)
50-59:
- Anaemia (lack of blood)
- Anxiety
- Catheter site erythema (redness of skin at catheter site)
- Catheter site swelling
- Chest pain
- Chronic left ventricular failure (long lasting functional impairment of left ventricle of heart)
- Death
- Decreased appetite
- Dehydration (dryness resulting from the removal of water)
- Fatigue (feeling of tiredness)
60+:
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Actinomycotic skin infection (infectious and inflammatory diseases affect the skin and the oral mucosa)
- Back pain
- Bone disorder
- Bone pain
- Breast calcifications (deposits of calcium that can be seen on a mammogram of the breast)
- Breast cancer metastatic
- Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
- Cellulitis (infection under the skin)
- Cervix inflammation
What are the existing conditions these people have? *
- Breast Cancer Female: 3 people, 27.27%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 18.18%
- Ovarian Cancer (cancer of ovary): 1 person, 9.09%
- Nausea (feeling of having an urge to vomit): 1 person, 9.09%
- Multiple Myeloma (cancer of the plasma cells): 1 person, 9.09%
- Metastases To Liver (cancer spreads to liver): 1 person, 9.09%
- Metastases To Kidney (cancer spreads to kidney): 1 person, 9.09%
- Metastases To Bone (cancer spreads to bone): 1 person, 9.09%
- Mesothelioma (rare type of cancer that occurs in the thin layer of cells lining the body's internal organs, known as the mesothelium): 1 person, 9.09%
- Malignant Peritoneal Neoplasm (cancer tumour of peritoneum): 1 person, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Roxicet and Compazine?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Roxicet and Compazine:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Roxicet:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Compazine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Roxicet and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Compazine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on acetaminophen; oxycodone hydrochloride and prochlorperazine maleate (the active ingredients of Roxicet and Compazine, respectively), and Roxicet and Compazine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Combipatch cause Smear Cervix Abnormal? - now
- Could Adalat cause Post Procedural Haemorrhage? - a second ago
- Could Ibuprofen cause Viral Pharyngitis? - 8 seconds ago
- Could Hydroxyzine cause Faeces Hard? - 10 seconds ago
- Sickle Cell Anemia and Fever - 12 seconds ago
- Could Amlodipine cause Squamous Cell Carcinoma Of Skin? - 13 seconds ago
- Could Ursodiol cause Urticaria? - 13 seconds ago
- Could Septra cause Dyspnea? - 13 seconds ago
- Could Acyclovir cause Eye Pain? - 15 seconds ago
- Drug interactions of Q10 and Cytoxan - 31 seconds ago